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Cancers bearing the KRAS G13D mutation are notable for their
distinct clinical behavior relative to other oncogenic KRAS muta-
tions. We hypothesized that primary biochemical or biophysical
properties of KRAS G13D might contribute to these clinical
observations and as part of our study undertook structural studies
using x-ray crystallography. In this data article we discuss several
x-ray diffraction datasets that yielded structures of oncogenic
KRAS mutants including a high resolution (1.13 Å) structure of
KRAS G13D. The datasets are typical for high resolution x-ray
diffraction data and allow the construction of atomic resolution,
three dimensional structural models with high conﬁdence. This
data can be correlated with biochemical information such as
defects in substrate binding kinetics, GTPase activities and inter-
actions with the RAS effector RAF kinase.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
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J. Lu et al. / Data in Brief 5 (2015) 572–578 573ata formatFig.PDB format text ﬁle. Binary structure factor ﬁle in mtz format. Analyzed by
HKL2000/3000, Phenix and coot, Pymol, PDB2PQR with PARSE and PROPKAxperimental
factorsNonexperimental
featuresKRAS protein was crystallized by hanging drop vapor diffusion, cooled to 100 K
and subjected to synchrotron radiation from which diffraction images were
collected. Images were computationally analyzed to index reﬂections and extract
associated intensities. Molecular replacement was used to obtain phase infor-
mation. Computer aided modeling was used to generate reﬁned atomic coordi-
nates for KRAS proteins and to evaluate electrostatic potentialata source
locationDallas, United Statesata accessibility Protein coordinate data is publically available in the RCSB Protein Database
(http://www.rcsb.org/) using the identiﬁers 4TQ9, 4QL3, 4TQA, 4WA7. X-ray
diffraction images are available from the SBGRID data repository at https://data.
sbgrid.org/dataset/157/; doi:10.15785/SBGRID/157Value of the data
 G13D has the most rapid nucleotide exchange kinetics among common KRAS mutants enabling
hyper-auto-activation. A high resolution structure of G13D provides an explanation based on the
electrostatic potential of the protein surface.
 KRAS structures may assist with efforts to design compounds that directly inhibit oncogenic KRAS
proteins.
 KRAS structures may assist with constructing subclassiﬁcation schemes for KRAS-containing
tumors to direct tailored therapies.1. Data
1.1. Data collection and structure determination of KRAS G13D
The x-ray diffraction data set for KRAS G13D is similar in nature and quality to datasets for other
KRAS mutants collected as part of this study. The primary KRAS G13D image data consists of 450
diffraction images that were each collected during a 0.5° rotation of the crystal for a total of 225° of1. X-ray diffraction image from the G13D dataset collected at APS 19-1D.
Table 1
X-ray crystallography statistics for data collection and reﬁnement.
Data Collection Reﬁnement
Source APS 19-1D Resolution 27-1.13
Wavelength (Å) 0.97924 Reﬂections used 109,383
Space group C2 Reﬂections for R-Free 1980
Unit cell Non-hydrogen atoms 3188
a, b, c (Å) 66.2, 41.3,
114.5
Protein 2764
α, β, γ (deg.) 90, 105, 90 Water 424
Resolution (Å) 27.2-1.13 R-work 0.14
Unique reﬂections 111,363 R-free 0.169
Redundancy 4.4 (4.0) RMS deviations
Completeness (%) 99.7 (99.3) Bond lengths (Å) 0.011
R-merge 0.05 (0.52) Bond angles (°) 1.476
oI/σ4 34.6 (2.0) Average B-factor (Å2) 18
Wilson B-factor (Å2) 11.7
Ramachandran plot (%)
Favored/allowed/
disallowed
99.7/0.3/0.0
MolProbity score 0.74 (99%)
Fig. 2. Representative portion of the 1.13 Å electron density map with the superimposed molecular model. (A) Atoms for
switch I residues 30–38 are clearly observed in the 2fo-fc (σ¼1.0) density map. (B) An fo-fc omit map (σ¼3.0) for GDP and
Asp13 side chain shows strong positive density for GDP and the Asp13 side chain. (C) Interface between symmetric molecules.
Asp13 (showed in magenta) does not participate in any crystallographic contacts. Molecules in the crystal lattice are differ-
entially colored red, green and blue.
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There is no evidence of salt or crystalline water (ice) formation (Fig. 1). The KRAS G13D crystals were
observed to belong to the monoclinic space group C2 with unit cell dimensions a¼66.2 Å, b¼41.3 Å,
c¼91.8 Å, α¼γ¼90° and β¼105°. Spots with sufﬁcient intensity above background to be statistically
useful extended to a resolution of 1.13 Å with 99.7% of expected spots visible at that resolution. In
total 111,363 unique reﬂections were measured with an overall redundancy of 4.4. All statistics for
data processing indicate a high quality dataset (Table 1). Molecular replacement was used to obtain
phase information and after several rounds of a combination of automated and manual reﬁnements, a
model consisting of 3188 non-hydrogen atoms was constructed with excellent statistics of 14%
R-work, 16.9% R-free and 18.0 Å2 average B-factor. Given the large number of unique reﬂections and
high resolution of the data, anisotropic B factor reﬁnement was done. Table 1 summarizes the ﬁnal
statistics for data processing and reﬁnement.
Fig. 3. Crystal structures of KRAS WT (green) and G13D (cyan). (A) Superimposition of wild type KRAS and G13D. The con-
formations of switch I and II regions are almost identical. (B) Backbone interactions of G13D. The Asp13 main chain amide is
2.8 Å away from β-phosphate of GDP and carbonyl is 2.8 Å away from the amine of Lys117. (C) 2D scheme of Hydrogen bonding
between β-phosphate of GDP and backbone of P-loop (residues 13–17) in WT (left) and G13D (right).
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1.2.1. Electron density map
In this 1.13 Å structure, there are two molecules in the asymmetric unit and each shows strong and
easily interpretable electron density for the backbone, as well as side chains (Fig. 2A). All loops,
including switch I (residues 30–38) and II (residues 60–76) whose conformations undergo a con-
formational “switch” depending on if bound to GTP vs. GDP, are in well-deﬁned density. Calculation of
a fo-fc map where GDP and the side chain of residue 13 were omitted shows strong density corre-
sponding to the aspartate side chain and GDP (Fig. 2B). The conformation of Asp13 is not constrained
by intermolecular interactions in the crystal packing (Fig. 2C). We also identiﬁed strong electron
density (14.0 sigma 2fo-fc map, 51.5 sigma fo-fc map) near the β-phosphate of GDP consistent with a
coordinated Mg2þ atom as observed in prior KRAS structures. The G13D mutation has little effect on
the overall structure of the protein with global RMSD of 0.146 Å compared with wildtype KRAS
(PDBID 4OBE). Both switch I and II regions are in the inactive open conformation, similar to the
wildtype and mutant KRAS structures we reported previously [1] (Fig. 3A).
1.2.2. Guanine nucleotide binding site
Interactions between KRAS G13D and GDP are similar to previously reported interactions seen in
wild type KRAS protein [2,3]. Speciﬁcally the backbone nitrogen of residue 13 interacts with the β-
phosphate of GDP, and the main chain carbonyl is hydrogen bound to the amine of Lys117. Intro-
duction of Asp13 does not alter the position of its backbone, nor disrupt these interactions (Fig. 3B). In
Fig. 4. Electrostatic potential maps were calculated using the PDB2PQR server and APBS tools for WT, G12D and G13D. Positive
charge is showed in blue and negative charge is showed in red. Negative charge from G13D are highlighted with a green circle.
J. Lu et al. / Data in Brief 5 (2015) 572–578576fact, the positioning of main chain atoms in the entire phosphate binding loop (also known as the
P-loop, residues 13–17) are unaffected by this mutation, and remains within hydrogen bonding dis-
tance of the β-phosphate of GDP, stabilizing the negative charged β phosphate [4] (Fig. 3C).
The aspartate side chain is positioned above the α-phosphate and is rotated towards the ribose ring of
GDP with the carboxylic oxygen sitting 3 angstroms from carbon-5 of the ribose sugar, although no
direct interaction is observed. Tyr32 on switch I coordinates with a water molecule adjacent to the
β-phosphate, allowing it to stabilize negative charges during GTP hydrolysis [5]. Modeling G13D onto
the activated KRAS structure demonstrates that the side chain atoms of Asp13 are 4 Å from Tyr32
and face the opposite side of the P-loop, and would not be predicted to have an impact on the
interaction between Tyr32 and GTP.
1.3. Electrostatic potential maps of protein surface
As part of our study we measured the rate of nucleotide exchange of various common KRAS
mutant isoforms and found that KRAS G13D stood out as having particularly high rates of nucleotide
exchange (see Ref. [6], Fig. 1). In an attempt to understand this phenomenon we calculated the
electrostatic potentials at the solvent interfaces of G13D, G12D and wild type KRAS. The P-loop region,
which includes residues 12 and 13, is above the guanosine diphosphate and strongly positive facil-
itating binding of the negatively charged phosphates in wild type KRAS (Fig. 2, PDB ID: 4OBE).
However, the carboxyl portion of aspartate 13 introduces a signiﬁcant negative charge in this region,
altering the local electrostatic environment. In contrast, the electrostatic map of G12D KRAS calcu-
lated from the published structure (PDB ID: 4EPR) demonstrates much less disruption of the posi-
tively charged binding pocket because in that case the side chain of Asp 12 is rotated away from the
phosphates (Fig. 4). The repulsion between the negatively charged carboxylic acid of Asp13 and the
α-phosphate of GTP or GDP effectively causes a more rapid exchange of guanine nucleotides as
compared to wildtype KRAS and other KRAS mutant isoforms.2. Experimental design, materials and methods
2.1. Protein preparation and crystallization
Protein was expressed and puriﬁed as described previously [1]. Point mutations were generated
using the GeneArts site-directed mutagenesis system (Life Technologies). Due to precipitation issue,
5 mM GDP was added to the buffer after IMAC column to stabilize the protein. Finally, G13D was
buffer exchanged into 20 mM Tris pH 8.0, 50 mM NaCl, 1 mM DTT, 5 mM GDP and stored at 80 °C
until use. KRAS G13D was unique amongst the KRAS mutants we puriﬁed in its requirement for GDP
in the puriﬁcation buffers to prevent protein precipitation. Crystals of KRAS mutants grew from
hanging vapor diffusion drops with following condition: 0.2 M sodium acetate pH 4.5, 0.1 M Tris pH
J. Lu et al. / Data in Brief 5 (2015) 572–578 5778.5, 26% PEG 3350. 100–300 mM square cubic crystals normally appeared after 5 days incubation at
20 °C. Crystals were cryoprotected in 15% glycerol and ﬂash frozen in liquid nitrogen.
2.2. Crystal structure determination
Diffraction images were collected at the advanced photon source beamline 19-ID. Data was inte-
grated and scaled using HKL2000/3000 packages [7]. Molecular replacement was performed with
4OBE as the search model using Phaser software. Manual and automated model building and
reﬁnement were performed using Phenix package and coot software [8,9]. Figure images were
prepared using Pymol (The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC). Final
model and scaled reﬂection data was deposited at the protein databank. Final collection and
reﬁnement statistics are presented in Table 1. 2D interaction schemes were prepared in Maestro
(Schrödinger Release 2015-3: Maestro, version 10.3, Schrödinger, LLC, New York, NY, 2015). Electro-
static maps of WT KRAS (PDB ID 4OBE) and KRAS G13D were generated using the PDB2PQR server
[10,11] with the PARSE force ﬁeld and PROPKA to assign protonation states. Images were prepared
using the Pymol APBS tools plugin [12].Acknowledgment
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